N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
Dana-Farber Cancer Institute
Massachusetts General Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Faculdade de Farmácia
Brigham and Women's Hospital
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Erasmus Medical Center
University of Central Florida
Peking University People's Hospital
Fundacion CRIS de Investigación para Vencer el Cáncer
National Taiwan University Hospital
Capital Medical University
Capital Medical University
Leiden University Medical Center
Uppsala University Hospital
OHSU Knight Cancer Institute
The First Affiliated Hospital with Nanjing Medical University
Grupo Espanol de Investigacion en Sarcomas
Rush University Medical Center
The First Affiliated Hospital of Guangzhou Medical University
Peking University People's Hospital
Poitiers University Hospital
University of South Florida
Peking University People's Hospital
Peking Union Medical College Hospital
Peking University People's Hospital
University of Colorado, Denver
Catharina Ziekenhuis Eindhoven
The University of Hong Kong
Women's Hospital School Of Medicine Zhejiang University
Barretos Cancer Hospital
Anhui Medical University
Anhui Medical University
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Zhejiang University
Alliance for Clinical Trials in Oncology
Chang Gung Memorial Hospital
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Virginia Commonwealth University
Zhejiang Cancer Hospital
Indiana University
Southern China Urology Cancer Consortium
Johns Hopkins University
Barbara Ann Karmanos Cancer Institute
University of Chicago